0074-7096 : Qulipta 30 mg Oral Tablet


NDC: 0074-7096
Labeler: Abbvie Inc.
Product Type: Human Prescription Drug
Drug Name:  Qulipta
Dosage Form: Oral Tablet
Application #: NDA215206
Rev. Date: 


NDC Package Codes:

  • 0074-7096-04: 4 TABLET IN 1 BOTTLE (0074‑7096‑04)
  • 0074-7096-30: 30 TABLET IN 1 BOTTLE (0074‑7096‑30)

Active Ingredients:

  • Atogepant

Dosage Strength:

  • 30 mg

Pharmaceutical Classes:

  • Calcitonin Gene-related Peptide Receptor Antagonist [EPC]
  • Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0074-7094 Qulipta 60 mg Oral Tablet by Abbvie Inc.
  • 0074-7095 Qulipta 10 mg Oral Tablet by Abbvie Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0074-7096 QR Code

< Prev: 0074-7095Next: 0074-7098 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.